We are live on ! Find out more
BGM

Burkehill Global Management Portfolio holdings

AUM $2.02B
1-Year Est. Return 85.32%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+85.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.52B
AUM Growth
-$242M
Cap. Flow
-$232M
Cap. Flow %
-15.26%
Top 10 Hldgs %
29.41%
Holding
211
New
70
Increased
9
Reduced
6
Closed
53

Top Buys

Rank Stock Value
1
ITT icon
ITT
ITT
+$62.7M
2
EL icon
Estee Lauder
EL
+$43.7M
3
ROL icon
Rollins
ROL
+$42.6M
4
MDLN
Medline Inc
MDLN
+$40.9M
5
O icon
Realty Income
O
+$34.7M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$89.8M
2
BRO icon
Brown & Brown
BRO
+$70.3M
3
LTM
LATAM Airlines Group S.A.
LTM
+$43M
4
VRSN icon
VeriSign
VRSN
+$42.1M
5
FOX icon
Fox Class B
FOX
+$30.6M

Sector Composition

Rank Sector Weight
1 Industrials 22.84%
2 Healthcare 18.52%
3 Financials 14.15%
4 Consumer Discretionary 12.53%
5 Technology 11.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRCB
101
Black Rock Coffee Bar Inc
BRCB
$159M
$2.78M 0.18%
125,000
METC icon
102
Ramaco Resources Class A
METC
$649M
$2.7M 0.18%
+150,000
New +$3.94M
SHC icon
103
Sotera Health
SHC
$5.38B
$2.65M 0.17%
+150,000
New +$2.48M
WVE icon
104
Wave Life Sciences
WVE
$1.2B
$2.55M 0.17%
+150,000
New +$1.52M
TARA icon
105
Protara Therapeutics
TARA
$232M
$2.4M 0.16%
+450,000
New +$2.5M
NRIX icon
106
Nurix Therapeutics
NRIX
$2.65B
$2.26M 0.15%
+118,972
New +$1.71M
AVAH icon
107
Aveanna Healthcare
AVAH
$2.07B
$2.25M 0.15%
+275,000
New +$2.48M
EYPT icon
108
EyePoint Inc
EYPT
$1.2B
$2.1M 0.14%
+115,000
New +$1.63M
FDMT icon
109
4D Molecular Therapeutics
FDMT
$562M
$2.06M 0.14%
+275,000
New +$2.79M
AKR icon
110
Acadia Realty Trust
AKR
$2.84B
$2.05M 0.14%
100,000
CAI
111
Caris Life Sciences
CAI
$6.43B
$2.02M 0.13%
75,000
VRDN icon
112
Viridian Therapeutics
VRDN
$2.67B
$2.02M 0.13%
+65,000
New +$1.78M
BNTC icon
113
Benitec Biopharma
BNTC
$468M
$2.02M 0.13%
+150,000
New +$2.07M
AVBP icon
114
ArriVent BioPharma
AVBP
$1.44B
$2.01M 0.13%
100,000
IMRX icon
115
Immuneering
IMRX
$292M
$1.97M 0.13%
300,000
HTFL
116
Heartflow Inc
HTFL
$2.49B
$1.89M 0.12%
65,000
KYTX icon
117
Kyverna Therapeutics
KYTX
$484M
$1.88M 0.12%
+200,000
New +$1.48M
ETOR
118
eToro Group
ETOR
$2.8B
$1.76M 0.12%
50,000
RDW icon
119
Redwire
RDW
$3.25B
$1.71M 0.11%
225,000
RAPT
120
DELISTED
RAPT Therapeutics
RAPT
$1.69M 0.11%
+50,000
New +$1.55M
MH
121
McGraw Hill
MH
$2.22B
$1.65M 0.11%
100,000
ARX
122
Accelerant Holdings
ARX
$2.72B
$1.64M 0.11%
100,000
TERN
123
DELISTED
Terns Pharmaceuticals
TERN
$1.62M 0.11%
+40,000
New +$924K
AGRO icon
124
Adecoagro
AGRO
$1.36B
$1.59M 0.1%
+200,000
New +$1.57M
IMTX icon
125
Immatics
IMTX
$1.32B
$1.57M 0.1%
+150,000
New +$1.51M

Similar funds

Burkehill Global Management's Q4 2025 Portfolio in Review

As of Q4 2025, Burkehill Global Management held 211 positions worth $1.52B, down 14% from $1.76B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Burkehill Global Management withdrew a net $232M in Q4 2025, closing 53 positions and reducing 6 holdings. Its most notable exit was Sandisk, an estimated $89.8M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Burkehill Global Management opened a new position in ITT worth $60.7M.

  • Burkehill Global Management's largest Q4 2025 buy was ITT: 350,000 shares worth $60.7M.
  • Burkehill Global Management added most to SoFi Technologies in Q4 2025, an estimated $27.9M increase.
  • Burkehill Global Management's biggest Q4 2025 reduction was CoreWeave, cutting an estimated $15.2M.
  • Burkehill Global Management fully exited Sandisk in Q4 2025, selling an estimated $89.8M.
  • Burkehill Global Management's ten largest holdings make up 29% of its $1.52B portfolio in Q4 2025.
  • Burkehill Global Management opened 70 new positions and closed 53 in Q4 2025.
  • Burkehill Global Management's portfolio value fell 14% quarter-over-quarter to $1.52B.

Based on Burkehill Global Management's 13F filing for Q4 2025, filed 17 Feb 2026.